Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 23 2 2019
medline: 23 2 2019
entrez: 22 2 2019
Statut: ppublish

Résumé

This has now been corrected in both the PDF and HTML versions of the Article. The authors regret this error.

Identifiants

pubmed: 30787466
doi: 10.1038/s41436-019-0459-4
pii: S1098-3600(21)01667-1
pmc: PMC7608223
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1462

Subventions

Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 10124
Pays : United Kingdom

Commentaires et corrections

Type : ErratumFor

Auteurs

Andrew Lee (A)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.

Nasim Mavaddat (N)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.

Amber N Wilcox (AN)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Alex P Cunningham (AP)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.

Tim Carver (T)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.

Simon Hartley (S)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.

Chantal Babb de Villiers (CB)

The Primary Care Unit, Department of Public Health & Primary Care, University of Cambridge, Cambridge, UK.

Angel Izquierdo (A)

Hereditary Cancer Program, Epidemiology Unit and Girona Cancer Registry, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), Girona, Spain.

Jacques Simard (J)

Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, QC, Canada.

Marjanka K Schmidt (MK)

Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Fiona M Walter (FM)

The Primary Care Unit, Department of Public Health & Primary Care, University of Cambridge, Cambridge, UK.

Nilanjan Chatterjee (N)

Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Montserrat Garcia-Closas (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Marc Tischkowitz (M)

Department of Medical Genetics and National Institute for Health Research, Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.

Paul Pharoah (P)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

Douglas F Easton (DF)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.

Antonis C Antoniou (AC)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. a.antoniou@srl.cam.ac.uk.

Classifications MeSH